28th September 2023
21st September 2023
The Endpoints 11: The biotech startups making the biggest bets with the most exciting science in 2023
19th September 2023
ReCode Therapeutics Announces Closing of Extension to Series B Financing
2nd August 2023
Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement
11th May 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”
27th April 2023
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital
13th April 2023